How has the Telstra (ASX:TLS) share price performed since reporting results?

Here's what's been happening with this telco giant's shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Telstra Corporation Ltd (ASX: TLS) share price was a reasonably positive performer on Wednesday.

The telco giant's shares rose 0.5% to $3.95.

2 smiling women looking at a phone.

Image source: Getty Images

How has the Telstra share price performed since reporting its results?

Following the small rise in the Telstra share price yesterday, the company's shares have now risen a touch over 3.1% since the release of its results.

However, this doesn't tell the whole story. Around six weeks ago when the company released its results, the market was already getting excited about a potential return to growth in FY 2022.

This was confirmed with its results.

Telstra's CEO, Andy Penn, commented: "2021 was a really significant year for Telstra. We delivered results in line with guidance and we are seeing the focus and discipline on T22 pay off. It represents a turning point in our financial trajectory. Our second half underlying EBITDA was up on the first half, and our guidance for FY22 underlying EBITDA is $7.0-7.3 billion, which represents mid to high single digit growth."

However, with the market already pricing this in, the response by the Telstra share price was modest.

Though, one thing that certainly wasn't modest, were the gains the company's shares made prior to its results.

Demand for its shares has been strong in 2021, leading to the Telstra share price being one of the best performing large caps this year. For example, since the start of the year, the company's shares are up a sizeable 31%.

Where next for the company's shares?

The good news is that the Telstra share price has been tipped to rise further by a number of leading brokers.

One of those is Morgans. In response to its T25 strategy update last week, the broker retained its add rating and lifted its price target to $4.44.

This means there's still potentially a further 12.5% upside for Telstra's shares over the next 12 months. Food for thought.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
ASX Share Market News

Record breaker! The ASX 200 just hit a fresh all-time high

Investors just sent the ASX 200 into uncharted territory.

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
ASX Share Market News

Why is everyone talking about Domino's, Light & Wonder and BHP shares on Wednesday?

BHP, Light & Wonder, and Domino’s shares are turning heads today. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
ASX Share Market News

Earnings preview: can Cochlear shares rebound?

A decade low share price meets a make-or-break result.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »